HLAA Receives Permission from the FDA to Host a Meeting on Sensorineural Hearing Loss on May 25

HLAA has received permission from the U.S. Food and Drug Administration (FDA) to host an Externally-Led Patient-Focused Drug Development Meeting (EL-PFDD) for People and Families Living with Sensorineural Hearing Loss on Tuesday, May 25, from 10 a.m.-3 p.m., U.S. ET. This is a YouTube Live virtual meeting, and all are welcome to attend. You can pop in and out of the live meeting. The meeting will be recorded, and the recording will be available 48 hours after the meeting. This is the FIRST meeting of this kind on hearing loss that the FDA has given permission to hold.

Learn more: